Compare MDAI & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDAI | POM |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | China |
| Employees | 78 | N/A |
| Industry | Medical/Dental Instruments | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.6M | 47.2M |
| IPO Year | N/A | N/A |
| Metric | MDAI | POM |
|---|---|---|
| Price | $1.44 | $0.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.25 | N/A |
| AVG Volume (30 Days) | 731.6K | ★ 1.2M |
| Earning Date | 05-12-2026 | 05-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $63.80 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.11 | $0.19 |
| 52 Week High | $3.21 | $6.43 |
| Indicator | MDAI | POM |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 38.38 |
| Support Level | $1.25 | $0.20 |
| Resistance Level | $1.48 | $0.27 |
| Average True Range (ATR) | 0.15 | 0.04 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 42.58 | 6.88 |
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.